Related Experiment Video
Updated: Jun 19, 2026

10:05
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
11.9K
Perioperative Rhabdomyolysis in Obese Individuals Undergoing Bariatric Surgery: Current Status
Gilberto Duarte-Medrano1, Natalia Nuño-Lámbarri2,3, Marissa Minutti-Palacios1
1Anesthesiology Department, Medica Sur Clinic & Foundation, Mexico City 14050, Mexico.
Healthcare (Basel, Switzerland)
|October 25, 2024
Summary
Rhabdomyolysis, a muscle damage complication in bariatric surgery, is often caused by tissue compression and immobility. Early diagnosis and hydration are key, but preventing kidney injury remains a challenge.
Area of Science:
- Anesthesiology
- Nephrology
- Surgical Complications
Background:
- Rhabdomyolysis is a serious complication of bariatric surgery.
- Risk factors include tissue compression and prolonged immobility, particularly in the lower extremities, gluteal, and lumbar regions.
- Clinical signs include muscle pain, weakness, and dark urine, with elevated serum creatine kinase as the key biomarker.
Purpose of the Study:
- To highlight the challenges in diagnosing and managing rhabdomyolysis in bariatric surgery patients.
- To emphasize the importance of prevention and early intervention.
- To discuss current management strategies and limitations in preventing renal injury.
Main Methods:
- Review of existing literature on intraoperative rhabdomyolysis in bariatric surgery.
- Analysis of clinical presentation, diagnostic biomarkers, and risk factors.
- Discussion of perioperative management, including hydration and resuscitation protocols.
Main Results:
- Tissue compression and prolonged immobilization are primary risk factors for rhabdomyolysis.
- Elevated serum creatine kinase is the most reliable diagnostic marker.
- Intravenous fluid resuscitation with Lactated Ringer's or 0.9% saline is crucial for managing hydration.
Conclusions:
- Perioperative diagnosis requires high clinical suspicion in bariatric patients.
- Prevention is paramount in this vulnerable population.
- Early treatment initiation is vital, though preventing secondary renal injury remains challenging.
Related Concept Videos
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

